SEARCH

SEARCH BY CITATION

References

  • Ades, L., Mary, J.Y., Robin, M., Ferry, C., Porcher, R., Esperou, H., Ribaud, P., Devergie, A., Traineau, R., Gluckman, E. & Socie, G. (2004) Long-term outcome after bone marrow transplantation for severe aplastic anaemia. Blood, 103, 24902497.
  • Aitchison, R.G.M., Marsh, J.C.W., Hows, J.M., Russell, N.H. & Gordon-Smith, E.C. (1989) Pregnancy associated aplastic anaemia: a report of five cases and review of current management. British Journal of Haematology, 73, 541545.
  • Alter, B.P. (2007) Diagnosis, genetics and management of inherited bone marrow failure syndromes. American Society of Hematology. Education Program, 2007, 2939.
  • Appelbaum, F.R., Barrall, J., Storb, R., Ramberg, R., Doney, K., Sale, G.E. & Thomas, E.D. (1989) Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anaemia. Experimental Hematology, 15, 11341139.
  • Armenti, V.T., Ahlswede, K.M., Ahlswede, B.A., Jarrell, B.E., Moritz, M.J. & Burke, J.F. (1994) National Transplantation Pregnancy Registry – outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation, 57, 502506.
  • Bacigalupo, A., Hows, J.M., Gluckman, E., Nissen, C., Marsh, J., Van Lint, M.T., Congiu, M., De Planque, M.M., Ernst, P. & McCann, S. (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA Working Party. British Journal of Haematology, 70, 177182.
  • Bacigalupo, A., Chaple, M., Hows, J., Van Lint, M.T., McCann, S., Milligan, D., Chessells, J., Goldstone, A.H., Ottolander, J., Veer Van’t Korthof, E.T.E., Comotti, B., Coser, B., Broccia, G., Busi, A., Locascuilli, A., Catalono, L., Battista, R., Arcese, W., Carotenuto, M., Marmont, A.M. & Gordon-Smith, E.C. (1993) Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (Mpred) with or without androgens: a randomised trial from the EBMT SAA Working Party. British Journal of Haematology, 83, 145151.
  • Bacigalupo, A., Brand, R., Oneto, R., Bruno, B., Socie, G., Passweg, J., Locasciulli, A., Van Lint, M.T., Tichelli, A., McCann, S., Marsh, J., Ljungman, P., Hows, J., Marin, P. & Schrezenmeier, H. (2000a) Treatment of acquired severe aplastic anaemia: bone marrow transplantation compared with immunosuppressive therapy – The European Group for Blood and Marrow Transplantation experience. Seminars in Hematology, 37, 6980.
  • Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locascuilli, A., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Marotenuto, M., Coser, P., Barbui, T., Leoni, P. & Ferster, A., for the European Group for Blood and Bone Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midollo Osseo (GITMO) (2000b) Antilymphocyte globulin, cyclosporine, prednisolone and granulocyte colony stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood, 95, 19311934.
  • Bacigalupo, A., Locatelli, F., Lanino, E., Marsh, J., Socie, G., Maury, S., Prete, A., Locasciulli, A. & Cesaro, S. (2005) Fludarabine, cyclophosphamide and ATG for alternative donor transplants in acquired severe aplastic anaemia – a report of the EBMT SAA Working Party. Bone Marrow Transplantation, 41, 4550.
  • Bacigalupo, A., Locatelli, F., Lanino, E., Marsh, J., Socie, G. & Passweg, J. (2009) Fludarabine, cyclophosphamide with or without low dose TBI for alternative donor transplants in Acquired Aplastic Anemia (SAA): a report from the EBMT-SAA Working Party. Biology of Blood and Marrow Transplantation, 15, 5.
  • Bain, B.J., Clark, D.M., Lampert, I.A. & Wilkins, B.S. (2001) Bone Marrow Pathology, 3rd edn. Blackwell Science, Oxford.
  • Barker, J.N., Davies, S.M., DeFor, T., Ramsay, N.K.C., Weisdorf, D.J. & Wagner, J.E. (2001) Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood, 97, 29572961.
  • Baumelou, E., Guiguet, M. & Mary, J.Y., the French Cooperative Group for Epidemiological Study of Aplastic Anaemia (1993) Epidemiology of aplastic anaemia in France: a case control study. 1. Medical history and medication use. Blood, 81, 14711478.
  • BCSH Clinical Haematology Task Force (2000) Guidelines on the provision of facilities for the care of adult patients with haematological malignancies (including leukaemia and lymphoma and severe bone marrow failure). In: Standard Haematology Practice/3 (ed. by K.Wood), pp. 241252. Blackwell Publishing, Oxford.
  • Bean, M., Gordon, T., Appelbaum, F.R., Deeg, H.J., Schuening, F., Sale, G.E. & Storb, R. (1994) Gamma irradiation of pretransplant blood transfusions from unrelated donors prevents sensitisation to minor histocompatibility antigens on dog leukocyte antigen-defined canine marrow grafts. Transplantation, 57, 432436.
  • Bennett, J.M. & Orazi, A. (2009) Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach. Haematologica, 94, 264268.
  • Bodey, G.P., Bolivar, R. & Fainstein, V. (1982) Infectious complications in leukaemic patients. Seminars in Hematology, 19, 193.
  • Brodsky, R.A., Sensenbrenner, L.L. & Jones, R.J. (1996) Complete remission in severe aplastic anemia after high dose cyclophosphamide without bone marrow transplantation. Blood, 87, 491494.
  • Brodsky, R.A., Sensenbrenner, L.L., Douglas-Smith, B., Dorr, D., Seaman, P.J., Lee, S.M., Karp, J.E., Brodsky, I. & Jones, R.J. (2001) Durable treatment-free remission after high dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Annals of Internal Medicine, 135, 477483.
  • Brodsky, R., Chen, A., Brodsky, I. & Jones, R. (2004) High-dose cyclophosphamide as salvage therapy for severe aplastic anaemia. Experimental Hematology, 32, 435440.
  • Brown, K.E., Tisdale, J., Barrett, A.J., Dunbar, C.E. & Young, N.S. (1997) Hepatitis-associated aplastic anaemia. New England Journal of Medicine, 336, 10591064.
  • Camitta, B.M. (2000) What is the definition of cure for aplastic anemia? Acta Haematologica, 103, 1618.
  • Camitta, B.M., Rappeport, J.M., Parkman, R. & Nathan, D.G. (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood, 45, 355363.
  • Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., Varet, B. & Mayeux, P. (2002) Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. New England Journal of Medicine, 346, 469475.
  • Champlin, R.E., Perez, W.S., Passweg, J., Klein, J.P., Camitta, B.M., Gluckman, E., Bredeson, C. & Horowitz, M.M. (2007) Bone marrow transplantation for severe aplastic anemia: a randomised controlled study of conditioning regimens. Blood, 109, 45824585.
  • Chessells, J.M. (2001) Pitfalls in the diagnosis of childhood leukaemia. British Journal of Haematology, 114, 506511.
  • Clark, A.D. & Butt, N. (1997) Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant. Clinical and Laboratory Haematology, 19, 279281.
  • Dacie, J.V. & Lewis, S.M. (2001) Practical Haematology, 9th edn. (ed. by S.M.Lewis, B.J.Bain & I.Bates), pp. 219225. Churchill Livingstone, Elsevier.
  • Davies, J.K. & Guinan, E.C. (2007) An update on the management of severe idiopathic aplastic anaemia in children. British Journal of Haematology, 136, 549564.
  • Deeg, H.J., Leisenring, W., Storb, R., Nims, J., Flowers, M.E., Witherspoon, R.P., Sanders, J. & Sullivan, K.M. (1998) Long term outcome after marrow transplantation for severe aplastic anaemia. Blood, 91, 36373645.
  • Deeg, H.J., O’Donnell, M., Tolar, J., Agarwal, R., Harris, R., Feig, S.A., Territo, M.C., Collins, R.H., McSweeney, P.A., Copelan, E.A., Khan, S.P., Woolfrey, A. & Storer, B. (2006) Optimisation of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood, 108, 14851491.
  • Delord, C., Tooze, J.A., Saso, R., Marsh, J.C.W. & Gordon-Smith, E.C. (1998) Deficiency of glycosylphosphatidylinositol-anchored proteins in patients with aplastic anaemia does not affect response to immunosuppressive therapy. British Journal of Haematology, 101, 9093.
  • Di Bona, E., Rodeghiero, F., Bruno, B., Gabbas, A., Foa, P., Locasciulli, A., Rosanelli, C., Camba, L., Saracco, P., Lippi, A., Jori, A.P., Porta, F., De, R.V., Comotti, B., Iacopino, P., Dufour, C. & Bacigalupo, A. (1999) Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. British Journal of Haematology, 107, 330334.
  • Dokal, I. (2000) Dyskeratosis congenita in all its forms. British Journal of Haematology, 110, 768779.
  • Dunn, D.E., Tanawattanacharoen, P., Boccuni, P., Nagakurs, S., Green, S.W., Kirby, M.R., Kumar, M.S., Rosenfeld, S. & Young, N.S. (1999) Paroxysmal nocturnal haemoglobinuria cells in patients with bone marrow failure syndromes. Annals of Internal Medicine, 131, 401408.
  • Fleming, L.E. & Timmeny, W. (1993) Aplastic anaemia and pesticides. An etiologic association? Journal of Occupational Medicine, 35, 11061116.
  • Frickhofen, N., Heimpel, H., Kaltwasser, J.P. & Schrezenmeier, H., for the German Aplastic Anaemia Study Group (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomised trial comparing treatments of aplastic anaemia. Blood, 101, 12361242.
  • Fuhrer, M., Baumann, I., Faldum, A., Niemeyer, C., Janka-Schaub, G., Friedrich, W., Ebell, W., Borkhardt, A. & Bender-Goetz, C. (2005) Immunosuppressive therapy for aplastic anaemia in children: a more severe disease predicts better survival. Blood, 106, 21022104.
  • Gafter-Gvili, A., Fraser, A., Paul, M. & Leibovici, L. (2005) Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Annals of Internal Medicine, 142, 979995.
  • Garg, R., Faderl, S., Garcia-Manero, G., Cortes, J., Koller, C., Huang, X., York, S., Pierce, S., Brandt, M., Beran, M., Borthakur, G., Kantarjian, H. & Ravandi, F. (2009) Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome. Leukemia, doi:DOI: 10.1038/leu.2009.28.
  • Geary, C.G., Harrison, C.J., Philpott, N.J., Hows, J.M., Gordon-Smith, E.C. & Marsh, J.C.W. (1999) Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy. British Journal of Haematology, 104, 271274.
  • Gluckman, E., Rocah, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.-P., Fernandez, M. & Chastang, C., for the Eurocord Transplant Group and the European Blood and Marrow Transplantation Group (1997) Outcome of cord-blood transplantation from related and unrelated donors. New England Journal of Medicine, 337, 373381.
  • Gluckman, E., Rokicka-Milewska, R., Hann, I., Nikiforakis, E., Tavakoli, F., Cohen-Scali, S. & Bacigalupo, A. (2002) Results and follow-up of a phase III randomised study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia. British Journal of Haematology, 119, 10751082.
  • Gordon-Smith, E.C. (1991) Acquired aplastic anaemia. In: Hematology, Basic Principles and Practice (ed. by R.Hoffman, E.J.Benz, S.J.Shattil, B.Furie & H.J.Cohen), pp. 160171. Churchill Livingstone, New York.
  • Gordon-Smith, E.C., Marsh, J.C.W. & Geary, C.G. (1995) Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer. British Medical Journal, 311, 450451.
  • Gupta, V., Ball, S., Yi, Q., Sage, D., McCann, S., Lawler, M., Ortin, M., Freires, M., Hale, G., Waldmann, H., Gordon-Smith, E. & Marsh, J. (2004) Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Biology of Blood and Marrow Transplantation, 7, 867876.
  • Gupta, V., Gordon-Smith, E., Cook, G., Parker, A., Duguid, J., Wilson, K., Yi, Q. & Marsh, J. (2005a) A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders. British Journal of Haematology, 128, 110117.
  • Gupta, V., Ball, S., Sage, D., Ortin, M., Freires, M., Gordon-Smith, E. & Marsh, J. (2005b) Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplantation, 35, 467471.
  • Gupta, V., Brooker, C., Tooze, J.A., Yi, Q.-L., Sage, D., Turner, D., Kangasabapathy, P. & Marsh, J.C.W. (2006) Clinical relevance of cytogenetics abnormalities in adult patients with acquired aplastic anaemia. British Journal of Haematology, 134, 9599.
  • Gupta, V., Carreras, J., Bajorunaite, R., Gale, R.P., Sabloff, M., Aljurf, M., Schrezenmeier, H., Socié, G., Passweg, J., Ringdén, O., Pasquini, R., Marsh, J. & Eapen, M. (2008) Hematopoietic recovery and overall survival after HLA-matched sibling transplants for older patients with Severe Aplastic Anemia (SAA). Blood (ASH Annual Meeting Abstracts), 112, 2169.
  • Hall, C., Richards, S. & Hillmen, P. (2003) Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal haemoglobinuira (PNH). Blood, 102, 35873591.
  • Heimpel, H. (1996) When should the clinician suspect a drug-induced blood dyscrasia, and how should he proceed? European Journal of Haematology, 57(Suppl.), 1115.
  • Heimpel, H. (2000) Epidemiology and aetiology of aplastic anaemia. In: Aplastic Anaemia: Pathophysiology and Treatment (ed. by H.Schrezenmeier & A.Bacigalupo), pp. 97116. Cambridge University Press, Cambridge, UK.
  • Hendry, C.L., Marsh, J.C.W., Gordon-Smith, E.C. & Sivakumaran, M. (2002) Relapse of severe aplastic anaemia after influenza immunisation. British Journal of Haematology, 119, 283284.
  • Hill, A., Hillmen, P., Richards, S., Elebute, D., Marsh, J., Chan, J., Mojcik, C. & Rother, R. (2005) Sustained response and long term safety of eculizumab in paroxysmal nocturnal haemoglobinuria. Blood, 106, 25592565.
  • Hillmen, P., Hall, C., Marsh, J.C.W., Elebute, M., Bombara, M.P., Petro, B.E., Cullen, M.J., Richards, S.J., Rollins, S.A., Mojcik, C.F. & Rother, R.P. (2004) Effect of Eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine, 350, 552559.
  • Hillmen, P., Young, N.S., Schubert, J., Brodsky, R.A., Socié, G., Muus, P., Röth, A., Szer, J., Elebute, M.O., Nakamura, R., Browne, R., Risitano, A.M., Hill, A., Schrezenmeier, H., Fu, C.L., Maciejewski, J., Rollins, S.A., Mojcik, C.F., Rother, R.P. & Luzzatto, L. (2006) The complement inhibitor Eculizumab in paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine, 355, 12331243.
  • Hillmen, P., Muus, P., Dührsen, U., Risitano, A.M., Schubert, J., Luzzatto, L., Schrezenmeier, H., Szer, J., Brodsky, R.A., Hill, A., Socié, G., Bessler, M., Rollins, S.A., Bell, L., Rother, R.P. & Young, N.S. (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood, 110, 41234128.
  • Hows, J.M. (2001) Status of umbilical cord blood transplantation in the year 2001. Journal of Clinical Pathology, 54, 428434.
  • International Agranulocytosis and Aplastic Anaemia Study (1987) Incidence of aplastic anaemia: relevance of diagnosis criteria. Blood, 70, 17181721.
  • Ishiyama, K., Karasawa, M., Miyawaki, S., Ueda, Y., Noda, M., Wakita, A., Sawanobori, M., Nagai, H. & Nakao, S. (2002) Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy. British Journal of Haematology, 117, 747750.
  • Issaragrisil, S., Kaufman, D., Anderson, T., Chansung, K., Leaverton, P., Shapiro, S. & Young, N., the Aplastic Anaemia Study Group (2006) The epidemiology of aplastic anaemia in Thailand. Blood 107, 12991307.
  • Issaragrissil, S., Kauffmann, D.W., Anderson, T., Chansung, K., Thamprasit, T., Sinjurachai, J., Piankijagum, A., Porakkham, Y., Vannasaeng, S., Leaverton, P.E., Shapiro, S. & Young, N.S., the Aplastic Anaemia Study Group (1997) Low drug attributability of aplastic anaemia in Thailand. Blood, 89, 40344039.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (eds) (2001) Myelodysplastic syndromes. In: World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
  • Kahl, C., Leisenring, W., Deeg, H.J., Chauncey, T., Flowers, M., Martin, P., Sanders, J. & Storb, R. (2005) Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long term follow up. British Journal of Haematology, 130, 747751.
  • Kaito, K., Kobayashi, M. & Katayama, T. (1998) Long term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. British Journal of Haematology, 103, 297303.
  • Kaminsky, E.R., Hows, J.M., Goldman, J.M. & Batchelor, J.R. (1990) Pretransfused patients with severe aplastic anaemia exhibit high numbers of cytotoxic T lymphocyte precursors probable directed at non-HLA antigens. British Journal of Haematology, 76, 401405.
  • Kao, S.Y., Xu, W., Brandwein, J.M., Lipton, J.H., Messner, H.A., Minden, M.D., Schimmer, A.D., Schuh, A.C., Yee, K. & Gupta, V. (2008) Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapy. British Journal of Haematology, 143, 738743.
  • Kauffmann, D.W., Kelly, J.P., Jurgelon, J.M., Anderson, T., Issaragrisil, S., Wilhom, B.E., Young, N.S., Leaverton, P., Levy, M. & Shapiro, S. (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. European Journal of Haematology, 57(Suppl.), 2330.
  • Keidan, A.J., Tsatalas, C., Cohen, J., Cousins, S. & Gordon-Smith, E.C. (1986) Infective complications of aplastic anaemia. British Journal of Haematology, 63, 503508.
  • Kelsey, P., Murphy, M.F., Brown, M., Carrington, P., Hall, G., Jeffrey, R.R., Machin, S., Taylor, C. & Thomas, D. (2003) Guidelines for the use of platelet transfusions. British Journal of Haematology, 122, 1023.
  • Killick, S.B., Win, N., Marsh, J.C., Kaye, T., Yandle, A., Humphries, C., Knowles, S.M. & Gordon-Smith, E.C. (1997) Pilot study of HLA alloimmunisation after transfusion with pre-storage leucodepleted blood products in aplastic anaemia. British Journal of Haematology, 97, 677684.
  • Kobayashi, R., Yabe, H., Hara, J., Morimoto, A., Tsuchida, M., Mugishima, H., Ohara, A., Tsukimoto, I., Kato, K., Kigasawa, H., Tabuchi, K., Nakahata, T., Ohga, S. & Kojima, S., for the Japan Childhood Aplastic Anemia Study Group (2006) Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. British Journal of Haematology, 135, 693696.
  • Kodera, Y., Morishima, Y., Kato, S., Akiyama, Y., Sao, H., Matsuyama, T., Kawa, K., Sakamaki, H., Nakagawa, S., Hirabayashi, N., Dohi, H., Okamoto, S., Hiraoka, A., Gondo, H., Tsuchida, M., Harada, M., Asano, S., Juji, T., Sasazuki, T. & Takaku, F. (1999) Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukaemia and aplastic anaemia. Bone Marrow Transplantation, 24, 9951003.
  • Kosaka, Y., Yagasaki, H., Sano, K., Kobayashi, R., Ayukawa, H., Kaneko, T., Yabe, H., Tsuchida, Y., Ohga, S., Bessho, F., Nakahata, T., Tsikimoto, I. & Kojima, S., on behalf of the Japan Childhood Aplastic Anemia Study Group (2008) Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood, 111, 10541059.
  • Kurzrock, R., Paquette, R. & Gratwohl, A. (1997) Use of stem cell factor (Stemgen, SCF) and filgrastim (G-CSF) in aplastic anaemia patients who have failed ATG/ALG therapy. Blood, 90(Suppl. 1), 173a.
  • Kwon, J.Y., Lee, Y., Shin, J.C., Lee, J.W., Rha, J.G. & Kim, S.P. (2006) Supportive management of pregnancy-associated aplastic anemia. International Journal of Gynaecology and Obstetrics, 95, 115120.
  • Lancaster, T., Swart, A.M. & Jick, H. (1998) Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. British Medical Journal, 316, 667.
  • Lawler, M., McCann, S.R., Marsh, J.C., Ljungman, P., Hows, J., Vandenberghe, E., O’Riordan, J., Locasciulli, A., Socié, G., Kelly, A., Schrezenmeier, H., Marin, P., Tichelli, A., Passweg, J.R., Dickenson, A., Ryan, J. & Bacigalupo, A., for the Severe Aplastic Anaemia Working Party of the European Blood and Marrow Transplant Group (2009) Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. British Journal of Haematology, 144, 933945.
  • Leleu, X., Terriou, L., Duhamel, A., Moreau, A.-S., Andrieux, J., Dupire, S., Coiteux, V., Berthou, C., Micol, J.-B., Guieze, R., Facon, T. & Bauters, F. (2006) Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens. Annals of Hematology, 85, 711716.
  • Lim, Z., Brand, R., Martino, R., Biezen, A., Finke, J., Bacigalupo, A., Beelen, D., Devergie, A., Alessandrino, E., Willemze, R., Ruutu, T., Boogaerts, M., Falda, M., Jouet, J.-P., Niederwieser, D.W., Kroger, N., Mufti, G. & De Witte, T.M., for the MDS subcommittee of the Chronic Leukemia Working Party of the European group for Blood and Marrow Transplantation (EBMT) (2009) Allogeneic hematopoietic stem cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia. Journal of Clinical Investigation, in press.
  • Little, M.A., Abraham, K.A., Kavanagh, J., Connolly, G., Byrne, P. & Walshe, J.J. (2000) Pregnancy in Irish renal transplant recipients in the cyclosporine era. Irish Journal of Medical Science, 169, 1921.
  • Ljungman, P. (2000) Supportive treatment of patients with severe aplastic anaemia. In: Aplastic Anaemia, Pathophysiology and Treatment (ed. by H.Schrezenmeier & A.Bacigalupo), pp. 137153. Cambridge University Press, Cambridge, UK.
  • Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenemeir, H., Passweg, J. & Fuhrer, M. (2007) Outcome of patients with acquired aplastic anaemia given first line bone marrow transplantation or immunosuppression treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 91, 1118.
  • Locascuilli, A., Arcese, W., Locatelli, F., Di Bona, E. & Bacigalupo, A., Italian Aplastic Anaemia Study Group (2001). Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Lancet, 357, 4344.
  • Locatelli, F., Bruno, B., Zecca, M., Van Lint, M.T., McCann, S., Arcese, W., Dallorso, S., Di Bartolomeo, P., Fagioli, F., Locasciulli, A., Lawler, M. & Bacigalupo, A. (2000) Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood, 96, 16901697.
  • Maciejewski, J.P., Risitano, A., Sloand, E.M., Nunez, O. & Young, N.S. (2002) Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anaemia. Blood, 99, 31293135.
  • Maggio, A. (2007) Light and shadows in the iron chelation treatment of haematological diseases. British Journal of Haematology, 138, 407421.
  • Mao, P., Zhu, Z., Wang, H., Wang, S., Mo, W., Ying, Y., Li, Q. & Xu, Y. (2005) Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia. European Journal of Haematology, 75, 430435.
  • Margolis, D., Camitta, B.M., Pietoyga, D., Keever-Taylor, C., Baxter-Lowe, L.A., Pierce, K., Kupst, M.J., French, J., Truitt, R., Lawton, C., Murray, K., Garbrecht, F., Flomberg, N. & Casper, J. (1996) Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. British Journal of Haematology, 94, 6572.
  • Marin, P. (2000) Clinical presentation, natural course and prognostic factors. In: Aplastic Anaemia: Pathophysiology and Treatment (ed. by H.Schrezenmeier & A.Bacigalupo), pp. 117136. Cambridge University Press, Cambridge, UK.
  • Marsh, J.C.W. (2000) Hematopoietic growth factors in the pathogenesis and for the treatment of aplastic anemia. Seminars in Hematology, 37, 8190.
  • Marsh, J.C.W., Socie, G., Schrezenmeier, H., Tichelli, A., Gluckman, E., Ljungman, P., McCann, S.R., Raghavachar, A., Marin, P., Hows, J.M. & Bacigalupo, A., for the European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia (1994a) Haemopoietic growth factors in aplastic anaemia: a cautionary note. Lancet, 344, 172173.
  • Marsh, J.C.W., Abboudi, Z.H., Gibson, F.M., Scopes, J., Daly, S., O’ Shaunnessy, D.F., Baughan, A.S.J. & Gordon-Smith, E.C. (1994b) Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine (Ecstasy). British Journal of Haematology, 88, 281285.
  • Marsh, J., Schrezenmeier, H., Marin, P., Ilhan, O., Ljungman, P., McCann, S., Socie, G., Tichelli, A., Passweg, J., Hows, J., Raghavachar, A., Locascuilli, A. & Bacigalupo, A. (1999) A prospective randomised multicentre study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with non-severe aplastic anaemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood, 93, 21912195.
  • Marsh, J.C.W., Ball, S.E., Darbyshire, P., Gordon-Smith, E.C., Keiden, A.J., Martin, A., McCann, S.R., Merceica, J., Oscier, D., Roques, A.W.W. & Yin, J.A.L., on behalf of the British Committee for Standards in Haematology (BCSH) General Haematology Task Force (2003) Guidelines for the diagnosis and management of acquired aplastic anaemia. British Journal of Haematology, 123, 782801.
  • Marsh, J.C.W., Ganser, A. & Stadler, M. (2007) Hematopoietic growth factors in the treatment of acquired bone marrow failure states. Seminars in Hematology, 44, 138147.
  • Marsh, J.C.W., Socie, G., Tichelli, A., Schrezenmeier, H., Hochsmann, B., Risitano, A.M., Fuehrer, M., Bekassy, A., Korthof, E.T., Locasciulli, A., Ljungman, P., Bacigalupo, A., Camitta, B., Young, N.S. & Passweg, J. (2009) Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the EBMT Severe Aplastic Anaemia Working Party. 35th Annual Meeting of the EBMT. Bone Marrow Transplantation, 43(S1), 315a.
  • Maury, S., Viollier, R., Oneto, R., Anderlini, P., Aljurf, M., Garban, F., Cordonnier, C., Marsh, J., Bacigalupo, A. & Passweg, J., on behalf of the EBMT-SAA Working Party (2007) Overcoming the negative impact of age using fludarabine based conditioning regimens for HLA-identical sibling HSCT in patients with severe aplastic anaemia. Bone Marrow Transplantation, 39(S1), Abstract 327.
  • McCann, S.R., Passweg, J., Storb, R. & Deeg, H.J. (2000) HLA identical sibling bone marrow transplantation to treat severe aplastic anaemia. In: Aplastic Anaemia, Pathophysiology and Treatment (ed. by H.Schrezenmeier & A.Bacigalupo), pp. 230257. Cambridge University Press, Cambridge, UK.
  • McCann, S., Passweg, J., Bacigalupo, A., Locasciulli, A., Locatelli, A., Ryan, J., Schrezenmeier, H. & Lawler, M. (2007) The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia. Bone Marrow Transplantation, 39, 109114.
  • McKay, D. & Josephson, M. (2006) Pregnancy in recipients of solid organs – effects on mother and child. The New England Journal of Medicine, 354, 12811293.
  • Mikhailova, N., Sessarego, M., Fugazza, G., Cuima, A., De Filippi, S., Van Lint, M.T., Bregante, S., Valeriamai, A., Mordini, N., Lamparelli, T., Gualandi, F., Occhini, D. & Bacigalupo, A. (1986) Cytogenetic abnormalities in patients with aplastic anaemia. Haematologica, 81, 418422.
  • Montané, E., Ibáñez, L., Vidal, X., Ballarin, E., Pig, R., Garcia, N. & Laporte, J.-R., the Catalan Group for the Study of Agranulocytosis and Aplastic Anemia (2008) Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 93, 518523.
  • Muir, K.R., Chilvers, C.E.D., Harriss, C., Coulson, L., Grainge, M., Darbyshire, P., Geary, C., Hows, J., Marsh, J., Rutherford, T., Taylor, M. & Gordon-Smith, E.C. (2003) The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation. British Journal of Haematology, 123, 906914.
  • Myers, K.C. & Davies, S.M. (2009) Haemopoietic stem cell transplantation for bone marrow failure syndromes in children. Biology of Blood and Marrow Transplantation, 15, 279292.
  • National Blood Service (NBS) (2007) Clinical Guidelines for the use of Granulocyte Transfusions. Information document INF/MED/MA/006/02. http://hospital.blood.co.uk/library/pdf/INF_MED_MA_006_02_Granulocyte_Transfusions.pdf
  • Niederwieser, N., Pepe, M., Storb, R., Loughran, Jr, T.P. & Longton, G., for the Seattle Marrow Transplant Team (1988) Improvement in rejection, engraftment rate and survival without increase in graft versus host disease by high marrow cell dose in patients transplanted for aplastic anaemia. British Journal of Haematology, 69, 2328.
  • Ohara, A., Kojima, S. & Hamajima, N. (1997) Myelodysplasia and acute leukaemia as a late clonal complication in children with acquired aplastic anaemia. Blood, 90, 10091013.
  • Oosterkamp, H.M., Brand, A., Kluin-Nelemans, J.C. & Vandenbroucke, J.P. (1998) Pregnancy and severe aplastic anaemia: causal relation or coincidence? British Journal of Haematology, 103, 315316.
  • Packman, C.H. (1998) Pathogenesis and management of paroxysmal nocturnal haemoglobinuria. Blood Reviews, 12, 111.
  • Pamphilon, D.H., Rider, J.R., Barbara, J.A.J. & Williamson, L.M. (1999) Prevention of transfusion-transmitted cytomegalovirus infection. Transfusion Medicine, 9, 115123.
  • Parker, C., Omine, M., Richards, S., Nishimura, J., Bessler, M., Ware, R., Hillmen, P., Luzzatto, L., Young, N., Kinoshita, T., Rosse, W. & Socie, G., for the International PNH Interest Group (2005) Diagnosis and management of paroxysmal nocturnal haemoglobinuria. Blood, 106, 36993709.
  • Passweg, J.R., Socie, G., Hinterberger, W., Bacigalupo, A., Biggs, J.C., Camitta, B.M., Champlin, R.E., Gale, R.P., Gluckman, E., Gordon-Smith, E.C., Hows, J.M., Klein, J.P., Nugent, M.L., Pasquini, R., Rowlings, P.A., Speck, B., Tichelli, A., Zhang, M.J., Horowitz, M.M. & Bortin, M.M. (1997) Bone marrow transplantation for severe aplastic anaemia: has outcome improved? Blood, 90, 858864.
  • Passweg, J., Perez, W., Eapen, M., Camitta, B., Gluckman, E., Hinterberger, W., Hows, J., Marsh, J., Pasquini, R., Schrezenmeier, H., Socie, G., Zhang, M.J. & Bredeson, C. (2006) Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anaemia. Bone Marrow Transplantation, 37, 641649.
  • Piaggio, G., Podesta, M., Pitto, A., Sessavego, M., Figari, O., Fugazza, G., Benvenuto, F., Bruno, B., Van Lint, M.T., Truini, M., Frassoni, F. & Bacigalupo, A. (1999) Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy (IST). British Journal of Haematology, 107, 505511.
  • Porter, J.B. (2001) Practical management of iron overload. British Journal of Haematology, 115, 239252.
  • Prentice, A.G., Glasmacher, A., Hobson, R.P., Schey, S., Barnes, R.A., Donnelly, J.P. & Jackson, G. (2008) BCSH Guidelines on the management of invasive fungal infection during therapy for haematological malignancy. http://www.bcshguidelines.com/pdf/IFI_therapy.pdf .
  • Provan, D., Newland, A.N., Norfolk, D., Bolton-Maggs, P., Lilleyman, J., Greer, I., May, A., Murphy, M., Ouwehand, W. & Watson, S., for the British Committee for Standards in Haematology, General Haematology Task Force (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and pregnancy. British Journal of Haematology, 120, 574596.
  • Roberts, H.J. (1997) Effect of pentachlorophenol exposure. Lancet, 19, 279281.
  • Rosenberg, P.S., Alter, B.P., Socie, G. & Gluckamn, E. (2005) Secular trends in outcome for Fanconi anaemia patients who receive transplants: implications for future studies. Biology of Blood and Marrow Transplantation, 11, 672679.
  • Russell, N.H., Gratwohl, A. & Schmitz, N. (1998) Developments in allogeneic peripheral blood progenitor cell transplantation. British Journal of Haematology, 103, 594600.
  • Sanders, J.E., Hawley, J., Levy, W., Gooley, T., Buckner, C.D., Deeg, H.J., Doney, K., Storb, R., Sullivan, K., Witherspoon, R. & Appelbaum, F.R. (1996) Pregnancies following high dose cyclophosphamide with or without high dose busulphan or total body irradiation and bone marrow transplantation. Blood, 87, 30453052.
  • Saracco, P., Quarello, P., Iori, A.P., Zecca, M., Longoni, D., Svahn, J., Varotto, S., Vecchio, G.C., Dufour, C., Ramenghi, U., Bacigalupo, A. & Locasciulli, A. (2008) Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow up. British Journal of Haematology, 140, 197205.
  • Saso, R., Marsh, J., Cevreska, L., Szer, J., Gale, R.P., Rowlings, P.A., Passweg, J.R., Nugent, M.L., Luzzatto, L., Horowitz, M.M. & Gordon-Smith, E.C. (1999) Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, 104, 392396.
  • Scheinberg, P., Nunez, O. & Young, N. (2006a) Re-treatment with rabbit antithymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. British Journal of Haematology, 133, 622627.
  • Scheinberg, P., Nunez, O., Wu, C. & Young, N. (2006b) Treatment of severe aplastic anaemia with combined immunosuppression: antithymocyte globulin, ciclosporin and mycophenolate mofetil. British Journal of Haematology, 133, 606611.
  • Scheinberg, P., Fischer, S.H., Nunez, O., Wu, C.O., Sloand, E.M., Cohen, J.I., Young, N.S. & Barrett, A.J. (2007) Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anaemia. Blood, 109, 32193224.
  • Scheinberg, P., Wu, C.O., Nunez, O. & Young, N.S. (2009) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. British Journal of Haematology, 144, 206216.
  • Schrezenmeier, H., Marin, P., Raghavachar, A., McCann, S.R., Hows, J., Gluckman, E., Nissen, C., Van’t Korthof Veer, E.T., Ljungman, P. & Hinterberger, W. (1993) Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. British Journal of Haematology, 85, 371377.
  • Schrezenmeier, H., Marsh, J.C.W., Stromyer, P., Heimpel, H., Gordon-Smith, E.C. & Raghavachar, A. (1995a) A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia. British Journal of Haematology, 90, 283292.
  • Schrezenmeier, H., Hertenstein, B., Wagner, B., Raghavachar, A. & Heimpel, H. (1995b) A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins – rapid communication. Experimental Hematology, 23, 8187.
  • Schrezenmeier, H., Bacigalupo, A., Aglietta, M., Camitta, B., Frickhofen, N., Fuhrer, M., Gluckamn, E., Gratwohl, A., Heimpel, H., Hows, J., Kojima, S., Locasciulli, A., Marmont, A., Marin, P., Marsh, J., McCann, S., Passweg, J., Pasquini, R., Podesta, M., Socie, G., Storb, R., Tichelli, A., Torok-Storb, B., Wodnat-Filipovicz, A. & Young, N. (2000) Consensus document for treating aplastic anaemia. Consensus document of a group of international experts. In: Aplastic Anaemia, Pathophysiology and Treatment (ed. by H.Schrezenmeier & A.Bacigalupo), pp. 308318. Cambridge University Press, Cambridge, UK.
  • Schrezenmeier, H., Bacigalupo, A., Dohner, H., Ramenghi, A., Locascuilli, A., Blundell, E., Platzebecker, U., Marsh, J., Raghavachar, A., Reinold, H., Weh, E., Thiel, E. & Passweg, J. (2003) Mycophenolate mofetil as treatment of patients with acquired aplastic anaemia failing to durably respond to standard immunosuppressive treatment. Bone Marrow Transplantation, 31(Suppl. 1), 0363a.
  • Schrezenmeier, H., Passweg, J.R., Marsh, J.C.W., Bacigalupo, A., Bredeson, C.N., Bullorsky, E., Camitta, B.M., Champlin, R.E., Gale, R.P., Fuhrer, M., Klein, J.P., Locasciulli, A., Oneto, R., Schattenberg, A.V., Socie, G. & Eapen, M. (2007) Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood, 110, 13971400.
  • Serious Hazards of Transfusion (SHOT) Annual Report (2006) http://www.shotuk.org/SHOT%20reports%20&%20summaries%202006.htm
  • Smith, M.T. (1996) Overview of benzene-induced aplastic anaemia. European Journal of Haematology, 57(Suppl.), 107111.
  • Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S.R., Frickhofen, N., Veer-Korthof, E. & Gluckman, E. (1993) Malignant tumors occurring after treatment of aplastic anemia. The New England Journal of Medicine, 329, 11521157.
  • Socie, G., Rosenfeld, S., Frickhofen, N., Gluckman, E. & Tichelli, A. (2000) Late clonal diseases of treated aplastic anaemia. Seminars in Hematology, 37, 91101.
  • Socie, G., Mary, J.-Y., Schrezenmeier, H., Marsh, J., Bacigalupo, A., Locasciulli, A., Fuhrer, M., Bekassy, A., Tichelli, A. & Passweg, J. (2007) Granulocyte colony stimulating factor for severe aplastic anaemia: a survey by the European Group for Blood and Marrow Transplantation. Blood, 109, 27942796.
  • Stanley, C.W., Gottlieb, R., Zager, R., Eisenberg, J., Richmond, R. & Moritz, M.J. (1999) Developmental well-being in offspring of women receiving cyclosporine post-renal transplant. Transplantation Proceedings, 31, 241242.
  • Stern, M., Passweg, J., Locasciulli, A., Socie, G., Schrezenemeier, H., Bekassy, A., Fuehrer, M., Korthof, E., McCann, S., Tichelli, A., Zoumbos, N., Marsh, J.C., Bacigalupo, A. & Gratwohl, A. (2006) Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation, 82, 218226.
  • Styczynski, J., Einsele, M., De La Camara, R., Cordonnier, C., Ward, K.N., Kjungman, P. & Engelhard, D., for the European Conference on Infection in Leukemia (2008) Managemetn of HSV, VZV and EBV infections in patients with haematological malignancies and after SCT: guidelines from the Second European Confernece on Infections in Leukemia. Bone Marrow Transplantation, 43, 757770.
  • Sugimori, C., Chuhjo, T., Feng, X., Yamazaki, H., Takami, A., Teramura, M., Mizoguchi, H., Omine, M. & Nakao, S. (2005) Minor populations of CD55−CD59− blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anaemia. Blood, 107, 13081314.
  • Teramura, M., Kimura, A., Iwase, S., Yonemura, Y., Nakao, S., Urabe, A., Omine, M. & Mizoguchi, H. (2007) Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood, 110, 17561761.
  • Thomas, F.T., Griesedieck, G. & Thomas, J. (1984) Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies. Transplantation Proceedings, 16, 15611563.
  • Tichelli, A., Gratwohl, A., Nissen, C., Signer, E., Stebler Gysi, C. & Speck, B. (1992) Morphology in patients with severe aplastic anaemia treated with antilymphocyte globulin. Blood, 80, 337345.
  • Tichelli, A., Socie, G., Marsh, J., McCann, S., Hows, J., Schrezenmeier, H., Marin, P., Hinterberger, W., Ljungman, P., Ragavachar, A., Vant-Veer Korthof, E., Gratwohl, A. & Bacigalupo, A. (1996) Cytogenetic abnormalities in aplastic anaemia. Bone Marrow Transplantation, 7(Suppl. 1), 268a.
  • Tichelli, A., Passweg, J., Nissen, C., Bargetzi, M., Hoffman, T., Wodnar-Filipowicz, A., Signer, E., Speck, B. & Gratwohl, A. (1996) Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. British Journal of Haematology, 100, 393400.
  • Tichelli, A., Socie, G., Henry-Amar, M., Marsh, J., Passweg, J., Schrezenmeier, H., McCann, S., Hows, J., Ljungman, P., Marin, P., Raghavachar, A., Locasciulli, A., Gratwohl, A. & Bacigalupo, A. (1999) Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. Annals of Internal Medicine, 130, 193201.
  • Tichelli, A., Socie, G., Marsh, J., Barge, R., Frickhofen, N., McCann, S., Bacigalupo, A., Hows, J., Marin, P., Nachbaur, D., Symeonidis, A., Passweg, J. & Schrezenmeier, H., on behalf of the European Group for Blood and Marriow Transplantation (EBMT) Severe Aplastic Anemia Working Party (2002) Outcome of pregnancy and disease outcome among women with aplastic anemia treated with immunosuppression. Annals of Internal Medicine, 137, 164172.
  • Tisdale, J.F., Dunn, D.E., Geller, N., Plante, M., Nunez, O., Dunbar, C.E., Barrett, A.J., Walsh, T.J., Rosenfeld, S.J. & Young, N.S. (2000a) High dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet, 356, 15541557.
  • Tisdale, J.F., Dunn, D.E. & Majewski, J. (2000b) Cyclophosphamide and other new agents for the treatment of severe aplastic anemia. Seminars in Hematology, 37, 102109.
  • Tisdale, J.F., Maciejewski, J.P., Nunez, O., Rosenfeld, S.J. & Young, N.S. (2002) Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial. Blood, 100, 46684670.
  • Tuzuner, N. & Bennett, J.M. (1994) Reference standards for bone marrow cellularity. Leukemia Research, 18, 645647.
  • Tuzuner, N., Cox, C., Rowe, J.M., Watrous, D. & Bennett, J.M. (1995) Hypocellular myelodysplastic syndromes (MDS): new proposal. British Journal of Haematology, 91, 612617.
  • Vadhan-Raj, S. (2000) Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia. Seminars in Hematology, 36, 2834.
  • Vallejo, C., Montesinos, P., Rosell, A., Brunet, S., Perez, E., Petit, J., Sevilla, J., Martin, A., Arranz, R. & Serna, J. (2009) Comparison between lymphoglobuline and thymoglobuline-based immunosuppressive therapy as first-line treatment for patients with aplastic anaemia. Haematologica, 94 (Suppl. 2), 451 abs. 1112.
  • Van Besien, K., Tricot, G., Golichowski, A., Padilla, L. & Hoffman, R. (1991) Pregnancy associated aplastic anaemia-report of 3 cases. European Journal of Haematology, 47, 253256.
  • Van Kamp, H., Van Imhoff, G.W., De Wolf, J.T., Smit, J.W., Halie, M.R. & Vellenga, E. (1995) The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, 89, 7982.
  • Viallard, J.F., Boiron, J.M., Pawens, M., Moreau, J.F., Randu, V., Reiffers, J., Leng, B. & Pellegrin, J.L. (2000) Severe pancytopenia triggered by recombinant hepatitis B vaccine. British Journal of Haematology, 110, 230233.
  • Viollier, R., Socié, G., Tichelli, A., Bacigalupo, A., Korthof, E., Marsh, J., Cornish, J., Ljungman, P., Oneto, R., Bekassy, A., Fuehrer, M., Maury, S., Schrezenmeier, H., Van Lint, M.T., Wojcik, D., Locasciulli, A. & Passweg, J.R., for the working party aplastic anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT) (2007) Recent improvement in outcome of unrelated donor transplantation for aplastic anaemia. Bone Marrow Transplantation, 41, 4550.
  • Vulliamy, T. & Dokal, I. (2006) Dyskeratosis congenita. Seminars in Hematology, 43, 157166.
  • Vulliamy, T., Walne, A., Baskaradas, A., Mason, P., Marrone, A. & Dokal, I. (2005) Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells, Molecules and Diseases., 34, 257263.
  • Walne, A.J. & Dokal, I. (2009) Advances in the understanding of dyskeratosis congenita. British Journal of Haematology, 145, 164172.
  • Wilholm, B.-E., Kelly, J.P., Kaufmann, D., Issaragrissil, S., Levy, M., Anderson, T. & Shapiro, S. (1998) Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. British Medical Journal, 316, 666.
  • Williamson, L., Baglin, T., Copplestone, A., Darbyshire, P., Forna, K., Gibson, B., Knowles, S.M., Morgan, G., Norfolk, D., Richards, A., Todd, A., Warwick, R. & Webb, D. (1996) BCSH Guidelines for gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfusion Medicine, 6, 261271.
  • Willis, F., Marsh, J., Bevan, D., Killick, S., Lucas, G., Griffiths, R., Ouwehand, W., Hale, G., Waldmann, H. & Gordon-Smith, E. (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. British Journal of Haematology, 114, 891898.
  • Witherspoon, R.B., Storb, R., Pepe, M., Longton, G. & Sullivan, K.M. (1991) Cumulative incidence of secondary solid malignant tumors after conditioning with chemotherapy alone. Blood, 79, 289291.
  • Yin, S.N., Li, Y., Tian, F., Du, C. & Jin, C. (1987) Occupational exposure to benzene in China. British Journal of Industrial Medicine, 44, 192195.
  • Yin, S.-N., Hayes, R.B., Linet, M.S., Li, G.-L., Dosemeci, M., Travis, L.B., Zhang, Z.-N., Li, D.-G., Chow, W.-H., Wacholder, S. & Blot, W.J., the Benzene Study Group (1996) An expanded cohort study of cancer among benzene-exposed workers in China. Environmental Health Perspectives, 104(Suppl. 6), 13391341.
  • Young, N.S. & Alter, B.P. (eds) (1994) Aplastic Anaemia: Acquired and Congenital. WB Saunders, Philadelphia.
  • Young, N.S., Calado, R.T. & Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108, 25092519.
  • Zheng, Y., Liu, Y. & Chu, Y. (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Experimental Hematology, 34, 826831.